Interestingly, in breast and lung cancer cells, Orai3 was demonstrated to encode a homomeric SOCE channel whereas in prostate cancer cells Orai3 was shown to constitute a heteromeric ARC channel [25,32,40]. This evidence concerns the gene ARC and prostate cancer.